Mechanism-centric regulatory network identifies NME2 and MYC programs as markers of Enzalutamide resistance in CRPC. - Panja S; Truica MI; Yu CY; Saggurthi V; Craige MW; Whitehead K; Tuiche MV; Al-Saadi A; Vyas R; Ganesan S; Gohel S; Coffman F; et al. (Nature communications, 2024)